201 related articles for article (PubMed ID: 24151279)
1. Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures.
Irwin A; Khan SK; Jameson SS; Tate RC; Copeland C; Reed MR
Bone Joint J; 2013 Nov; 95-B(11):1556-61. PubMed ID: 24151279
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: An updated meta-analysis.
Xie J; Hu Q; Huang Q; Ma J; Lei Y; Pei F
Thromb Res; 2017 May; 153():28-36. PubMed ID: 28319822
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration.
Yi Z; Bin S; Jing Y; Zongke Z; Pengde K; Fuxing P
J Bone Joint Surg Am; 2016 Jun; 98(12):983-91. PubMed ID: 27307358
[TBL] [Abstract][Full Text] [Related]
4. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.
Li JF; Li H; Zhao H; Wang J; Liu S; Song Y; Wu HF
J Orthop Surg Res; 2017 Feb; 12(1):22. PubMed ID: 28153031
[TBL] [Abstract][Full Text] [Related]
5. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty.
Tuttle JR; Ritterman SA; Cassidy DB; Anazonwu WA; Froehlich JA; Rubin LE
J Arthroplasty; 2014 Aug; 29(8):1512-5. PubMed ID: 24630599
[TBL] [Abstract][Full Text] [Related]
6. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H).
Alshryda S; Mason J; Sarda P; Nargol A; Cooke N; Ahmad H; Tang S; Logishetty R; Vaghela M; McPartlin L; Hungin AP
J Bone Joint Surg Am; 2013 Nov; 95(21):1969-74. PubMed ID: 24196467
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis.
Yang ZG; Chen WP; Wu LD
J Bone Joint Surg Am; 2012 Jul; 94(13):1153-9. PubMed ID: 22623147
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological reduction of bleeding during hip endoprosthetic replacement].
de Jonge T
Orv Hetil; 2012 Oct; 153(41):1607-12. PubMed ID: 23045310
[TBL] [Abstract][Full Text] [Related]
9. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K).
Alshryda S; Mason J; Vaghela M; Sarda P; Nargol A; Maheswaran S; Tulloch C; Anand S; Logishetty R; Stothart B; Hungin AP
J Bone Joint Surg Am; 2013 Nov; 95(21):1961-8. PubMed ID: 24196466
[TBL] [Abstract][Full Text] [Related]
10. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty.
Gilbody J; Dhotar HS; Perruccio AV; Davey JR
J Arthroplasty; 2014 Apr; 29(4):681-4. PubMed ID: 24095586
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty.
Tan J; Chen H; Liu Q; Chen C; Huang W
J Surg Res; 2013 Oct; 184(2):880-7. PubMed ID: 23643299
[TBL] [Abstract][Full Text] [Related]
12. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total joint arthroplasty: A meta-analysis of randomized controlled trials.
Zhang XQ; Ni J; Ge WH
Int J Surg; 2017 Feb; 38():15-20. PubMed ID: 27913237
[TBL] [Abstract][Full Text] [Related]
13. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
Oremus K; Sostaric S; Trkulja V; Haspl M
Transfusion; 2014 Jan; 54(1):31-41. PubMed ID: 23614539
[TBL] [Abstract][Full Text] [Related]
14. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis.
Ho KM; Ismail H
Anaesth Intensive Care; 2003 Oct; 31(5):529-37. PubMed ID: 14601276
[TBL] [Abstract][Full Text] [Related]
15. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
Wind TC; Barfield WR; Moskal JT
J Arthroplasty; 2014 Feb; 29(2):387-9. PubMed ID: 23790499
[TBL] [Abstract][Full Text] [Related]
16. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
Wong J; Abrishami A; El Beheiry H; Mahomed NN; Roderick Davey J; Gandhi R; Syed KA; Muhammad Ovais Hasan S; De Silva Y; Chung F
J Bone Joint Surg Am; 2010 Nov; 92(15):2503-13. PubMed ID: 21048170
[TBL] [Abstract][Full Text] [Related]
17. Low Risk of Thromboembolic Events After Routine Administration of Tranexamic Acid in Hip and Knee Arthroplasty.
Madsen RV; Nielsen CS; Kallemose T; Husted H; Troelsen A
J Arthroplasty; 2017 Apr; 32(4):1298-1303. PubMed ID: 27843042
[TBL] [Abstract][Full Text] [Related]
18. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial.
Gomez-Barrena E; Ortega-Andreu M; Padilla-Eguiluz NG; Pérez-Chrzanowska H; Figueredo-Zalve R
J Bone Joint Surg Am; 2014 Dec; 96(23):1937-44. PubMed ID: 25471907
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery.
Irisson E; Hémon Y; Pauly V; Parratte S; Argenson JN; Kerbaul F
Orthop Traumatol Surg Res; 2012 Sep; 98(5):477-83. PubMed ID: 22854336
[TBL] [Abstract][Full Text] [Related]
20. [Single intravenous tranexamic acid dose to reduce blood loss in primary total knee replacement].
Sanz-Reig J; Parra Ruiz B; Ferrández Martínez J; Martínez López JF
Rev Esp Cir Ortop Traumatol; 2016; 60(2):106-12. PubMed ID: 26752323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
